gadolinium dtpa has been researched along with Multiple Sclerosis in 167 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (3.59) | 18.7374 |
1990's | 92 (55.09) | 18.2507 |
2000's | 39 (23.35) | 29.6817 |
2010's | 22 (13.17) | 24.3611 |
2020's | 8 (4.79) | 2.80 |
Authors | Studies |
---|---|
Großmann, A; Hauenstein, K; Kühn, I; Maschke, H; Storch, A; Walter, U; Weber, MA; Zettl, UK | 1 |
Cohen, JA; Jones, SE; Lowe, MJ; McGinley, MP; Nakamura, K; Ontaneda, D; Ruggieri, PM | 1 |
Bergendal, Å; Cananau, C; Fink, K; Forslin, Y; Fredrikson, S; Granberg, T; Ouellette, R; Sjöström, H; Wiberg, MK | 1 |
Cola, G; Dianzani, C; Landi, D; Mallio, CA; Marfia, GA; Parillo, M; Perrella, E; Quattrocchi, CC; Spani, F | 1 |
Brescia Morra, V; Brunetti, A; Cocozza, S; Criscuolo, C; Elefante, A; Falco, F; Lanzillo, R; Moccia, M; Monti, S; Palma, G; Petracca, M; Pontillo, G; Scaravilli, A; Tedeschi, E; Tranfa, M | 1 |
Berthele, A; Bussas, M; Grahl, S; Hemmer, B; Kirschke, JS; Mühlau, M; Pongratz, V; Zimmer, C | 1 |
Bageac, D; Cadavid, D; Cook, SD; DeBevits, JJ; Dhib-Jalbut, S; DiCamillo, PA; Hu, C; Karimeddini, D; Munbodh, R; Naismith, RT; Redko, S; Wang, L; Wolansky, L; Wu, R | 1 |
Codjia, P; Cotton, F; Durand-Dubief, F; Hannoun, S; Kocevar, G; Maucort-Boulch, D; Sappey-Marinier, D; Vukusic, S | 1 |
Gralla, J; Heldner, MR; Kamm, CP; Kellner-Weldon, F; Locher, C; Raabe, A; Schucht, P; Slotboom, J; Verma, RK; Wiest, R | 1 |
Chung, CF; Liang, HF; Nishioka, C; Sun, SW | 1 |
Bergendal, Å; Forslin, Y; Fredrikson, S; Granberg, T; Martola, J; Wiberg, MK | 1 |
Bergsland, N; Dwyer, MG; Hagemeier, J; Hojnacki, D; Kolb, C; Ramasamy, DP; Schweser, F; Weinstock-Guttman, B; Zivadinov, R | 1 |
Amezcua, L; Barisano, G; Bigjahan, B; Cen, S; Law, M; Lerner, A; Metting, S; Toga, AW | 1 |
Dellas, S; Fuhr, P; Grize, L; Kappos, L; Radue, EW; Schindler, C; Schlaeger, R | 1 |
Landtblom, AM; Lundberg, P; Tisell, A; Warntjes, JB | 1 |
Cirimele, V; Di Lazzaro, V; Errante, Y; Mallio, CA; Quattrocchi, CC; Zobel, BB | 1 |
Ali, M; Bure, L; Chen, JW; Hsieh, KL; Iwamoto, Y; Jacobs, AH; Li, D; Pulli, B; Schob, S; Wojtkiewicz, GR | 1 |
Bryan, RN | 1 |
Blystad, I; Ernerudh, J; Håkansson, I; Larsson, EM; Lundberg, P; Smedby, Ö; Tisell, A | 1 |
Fisher, E; Ford, C; Halper, J; Jones, DE; Khan, O; Li, D; Malhotra, A; Newsome, SD; Oh, J; Radue, EW; Rammohan, K; Reich, DS; Richert, N; Simon, JH; Stone, L; Traboulsee, A | 1 |
Bendszus, M; Jestaedt, L; Ladewig, G; Misselwitz, B; Solymosi, L; Stoll, G; Toyka, K | 1 |
Barkhof, F; Filippi, M; Jasperse, B; Knol, DL; Korteweg, T; Neacsu, V; Rovaris, M; Valsasina, P; Vrenken, H | 1 |
Kataoka, H; Taoka, T; Ueno, S | 1 |
Bagnato, F | 1 |
Furiya, Y; Kataoka, H; Kawahara, M; Kichikawa, K; Kiriyama, T; Morikawa, M; Sugie, K; Tanizawa, E; Taoka, T; Terashima, M; Tonomura, Y; Ueno, S | 1 |
Chen, SY; Hsu, CC; Hsu, WL; Hsueh, CJ; Kao, HW; Lin, WC; Liu, CC; Lo, CP; Wang, WY | 1 |
Berenguer, J; Blanco, Y; Graus, F; Hankiewicz, K; Llufriu, S; Pujol, T; Saiz, A; Squarcia, M; Villoslada, P | 1 |
Assaf, Y; Frenkel, D; Levy, H | 1 |
Al-Saeed, O; Athyal, R; Ismail, M; Sheikh, M | 1 |
Caffo, BS; Crainiceanu, CM; Gaitán, MI; Reich, DS; Shinohara, RT | 1 |
Akhtar, A; Anthony, DC; Campbell, SJ; Choudhury, RP; Krapitchev, A; Mardiguian, S; McAteer, MA; Serres, S; Sibson, NR | 1 |
Chatterjee, S; Kesavadas, C; Saini, J; Thomas, B | 1 |
Feng, W; Haacke, EM; Hewett, J; Hubbard, D; Katkuri, Y; Latif, Z; Trifan, G; Utriainen, D; Wu, Z | 1 |
Haacke, EM; Juvvigunta, F; Li, M | 1 |
Zivadinov, R; Zorzon, M | 1 |
Arru, G; Fois, ML; Pugliatti, M; Rosati, G; Sanna, A; Sotgiu, A; Sotgiu, S | 1 |
Bagnato, F; Frank, JA; Jeffries, N; McFarland, HF; Ohayon, JM; Richert, ND; Stone, RD | 1 |
Geng, Y; Guo, H; Hou, SF; Jiao, YJ; Liu, JH; Qiao, LY; Wang, H; Wei, XF; Wen, SG; Xu, XH; Yin, J; Zhang, H; Zhao, ZG | 1 |
Floridi, A; Gallai, V; Greco, L; Sarchielli, P | 1 |
Desai, NK; Runge, VM | 1 |
Filippi, M; Mancardi, G; Sardanelli, F | 1 |
Kealey, SM; Kim, Y; Provenzale, JM | 1 |
Horsfield, MA; Morgan, B | 1 |
Acar, G; Cakmakçi, H; Idiman, E; Idiman, F; Kirkali, G; Oktay, G; Ozakbaş, S | 1 |
Kappos, L; Kirsch, EC; Radü, EW; Scheffler, K; Schulte-Mönting, J; Taschner, CA; Wetzel, SG | 1 |
Cadavid, D; Cook, SD; Haghighi, MH; Joseph, G; Liu, J; Sethi, N; Sevdalis, E; Tulloch, K; Wolansky, LJ | 1 |
Carriero, A; Migazzo, E; Monaco, F; Saponaro, A; Scarabino, T; Stecco, A; Tesser, F | 1 |
Enriquez, MM; Fazekas, F; Fernandez, O; Filippi, M; Hommes, OR; Koelmel, HW; Lin, X; O'Connor, P; Pozzilli, C; Ropele, S; Sørensen, PS | 1 |
Ganter, C | 1 |
Leist, TP; Zivadinov, R | 1 |
Galassi, W; Hesselink, JR; Laopaiboon, M; Laopaiboon, V; Phuttharak, W | 1 |
Madabhushi, A; Moonis, G; Udupa, JK | 1 |
't Hart, BA; Bauer, J; Blezer, EL; Brok, HP; Nicolay, K | 1 |
Inglese, M; Jensen, JH; Lu, H | 1 |
Ge, Y | 1 |
Mueller, S; Prozorovski, T; Schnorr, J; Smyth, M; Taupitz, M; Tysiak, E; Wuerfel, J; Zipp, F | 1 |
Bakshi, R; Janardhan, V; Suri, S | 1 |
Ashjazadeh, N; Bagheri, MH; Borhani-Haghighi, A; Meshksar, A; Nabavizadeh, SA; Nikseresht, AR | 1 |
Ahn, SS; Guttmann, CR; Hsu, L; Jolesz, FA; Kikinis, R | 1 |
Anno, H; Koga, S; Miyata, E; Nomura, M; Suzumura, A; Yamamoto, H | 1 |
Larsson, HB | 1 |
Barkhol, F; Hommes, OR; Polman, CH; Tas, MW; Valk, J; van Walderveen, MA | 1 |
Fujii, K; Niimi, H; Sugita, K; Takanashi, J; Takatsuna, Y | 1 |
Christiansen, AP; Henriksen, O; Larsson, HB; Wanscher, B | 1 |
Baratti, C; Campi, A; Comi, G; Filippi, M; Martinelli, V; Rovaris, M; Scotti, G | 1 |
Clayton, D; Compston, A; Hale, G; Miller, D; Moreau, T; Moseley, I; Scolding, N; Thorpe, J; Waldmann, H; Wing, M | 1 |
Barkhof, F; Frequin, ST; Hommes, OR; Nauta, JJ; Scheltens, P; Tas, MW; Valk, J | 2 |
Andreula, C; Bastianello, S; Bozzao, A; D'Andrea, F; Gallucci, M; Gasperini, C; Millefiorini, E; Morino, S; Pozzilli, C; Trojano, M | 1 |
Albert, PS; Frank, JA; Maloni, H; McFarland, HF; Smith, ME; Stone, LA | 1 |
Barker, GJ; Brennan, A; Davie, CA; Hawkins, CP; McDonald, WI; Miller, DH; Tofts, PS | 1 |
Goodkin, DE; Ross, JS; Rudick, RA | 1 |
Cannella, B; Katz, D; McFarland, HF; McFarlin, DE; Raine, CS; Taubenberger, JK | 1 |
Friedman, DI; Haas, DC; Kent, PF | 1 |
Barkhof, F; Frequin, ST; Hommes, OR; Polman, CH; Tas, MW; Valk, J; van Walderveen, MA | 1 |
Bydder, GM; De Coene, B; Hajnal, JV; Pennock, JM | 1 |
Appel, B; Barkhof, F; Berry, I; Kappos, L; Miller, DH; Nauta, JJ; Scotti, G; Thompson, AJ; Tofts, PS; Yousri, T | 1 |
Cappa, SF; Capra, R; Cominelli, C; Gasparotti, R; Marcianoc, N; Mattioli, F | 1 |
Grant, EA; Karlik, SJ; Lee, D; Noseworthy, JH | 1 |
Albert, PS; Armstrong, M; Frank, JA; Maloni, H; Martin, R; McFarland, HF; McFarlin, DE; Smith, ME; Stone, LA | 1 |
Campi, A; Canal, N; Colombo, B; Comi, G; Filippi, M; Martinelli, V; Scotti, G; Yousry, T | 1 |
Barbosa, S; Birch, MK; Blumhardt, LD; Harding, SP; O'Brien, C | 1 |
Barker, GJ; Kendall, BE; Kidd, D; McDonald, WI; Miller, DH; Thompson, AJ; Thorpe, JW | 1 |
Gawne-Cain, M; Hodgson, T; Lai, M; MacManus, D; McDonald, WI; Miller, DH; Thompson, AJ; Webb, S | 1 |
Bressi, S; Campi, A; Colombo, B; Comi, G; Filippi, M; Kandziora, C; Martinelli, V; Scotti, G; Spuler, S; Voltz, R; Yousry, T | 1 |
Bolay, H; Karabudak, R; Onol, B; Saribaş, O; Selekler, K; Tacal, T | 1 |
Christiansen, P; Jensen, CV; Nordenbo, A; Ravnborg, M; Schreiber, K; Szpirt, W; Sørensen, PS; Wanscher, B | 1 |
Campi, A; Comi, G; Dousset, V; Filippi, M; Gerevini, S; Scotti, G | 1 |
Campi, A; Capra, R; Colombo, B; Comi, G; Filippi, M; Gasparotti, R; Marcianò, N; Prandini, F | 1 |
Bastianello, S; Bozzao, A; Bozzao, L; Buttinelli, C; Fieschi, C; Galgani, S; Gasperini, C; Koudriavtseva, T; Millefiorini, E; Perciaccante, G; Piazza, G; Pozzilli, C | 1 |
Bash, C; Frank, JA; Maloni, H; McFarland, H; Petrella, J; Stone, L | 1 |
Argentino, C; Di Biasi, C; Gasperini, C; Gualdi, GF; Iannilli, M; Koudriavtseva, T; Pozzilli, C; Trasimeni, G | 1 |
Avolio, C; Calò, A; De Robertis, F; Defazio, G; Livrea, P; Manzari, C; Simone, IL; Trojano, M | 1 |
Maloni, H; Martin, R; McFarland, HF; Stone, LA; Stüber, A | 1 |
Hartmann, M; Hohlfeld, R; Holler, E; Scheller, A; Spuler, S; Voltz, R; Wick, M; Yousry, T | 1 |
Conrad, B; Dietl, D; Gräfin von Einsiedel, H; Kornhuber, ME; Liebsch, R | 1 |
Fields, N; Frank, JA; Maloni, H; McFarland, H; Stone, LA; Tresley, RM | 1 |
Bash, CN; Calabresi, PA; Dambrosia, JM; Frank, JA; Maloni, H; McFarland, HF; Stone, LA; Tranquill, LR | 1 |
Campi, A; Colombo, B; Comi, G; Filippi, M; Pereira, C; Rossi, P | 1 |
Albert, PS; Bash, CN; Calabresi, PA; Frank, JA; Maloni, H; McFarland, HF; Stone, LA | 1 |
Iwasawa, T; Kurihara, H; Matoba, H; Matsubara, S; Nozaki, A; Ogi, A; Saito, K; Yoshida, T | 1 |
Bash, CN; Calabresi, PA; Frank, JA; Maloni, H; McFarland, HF; Stone, LA | 1 |
Lillås, F; Myhr, KM; Nilsen, R; Nortvedt, M; Nyland, H; Riise, T; Smievoll, AI | 1 |
Grossman, RI; Miki, Y; Samarasekera, S; Udupa, JK; van Buchem, MA; Wei, L | 1 |
Bastianello, S; Bozzao, L; Fieschi, C; Galgani, S; Gasperini, C; Horsfield, MA; Koudriavtseva, T; Millefiorini, E; Paolillo, A; Pozzilli, C | 1 |
Khoury, SJ; Weiner, HL | 1 |
Losseff, NA; MacManus, DG; McDonald, WI; Miller, DH; Moseley, IF; O'Riordan, JI; Phatouros, C; Thompson, AJ | 1 |
Bastianello, S; Capra, R; Filippi, M; Gasperini, C; Kuhne, I; Rovaris, M; Yousry, TA | 1 |
Bedell, BJ; Narayana, PA | 1 |
Blumhardt, LD; Clarke, H; Edwards, S; Irving, W; Zvartau, M | 1 |
Fesl, G; Filippi, M; Voltz, R; Walther, E; Yousry, TA | 1 |
Filippi, M; Gasperini, C; Mastronardo, G; Prandini, F; Rovaris, M; Yousry, TA | 1 |
Avolio, C; Defazio, G; Giuliani, F; Livrea, P; Paolicelli, D; Ruggieri, M; Trojano, M | 1 |
Bastianello, S; Capra, R; Comi, G; Filippi, M; Gasperini, C; Horsfield, MA; Kühne, I; Martinelli, V; Pozzilli, C; Prandini, F; Rovaris, M; Sormani, MP; Yousry, TA | 1 |
Filippi, M; Miller, DH; Silver, NC; Yousry, TA | 1 |
Bansil, S; Cook, SD; Holtz, CR; Jindal, S; Lee, HJ | 1 |
Barkhof, F; Filippi, M; Gasperini, C; Miller, DH; Molyneux, PD; Sormani, MP; Yousry, TA | 1 |
Comi, G; Filippi, M; Rodegher, M; Rovaris, M | 1 |
Grossman, RI; Kolson, DL; McGowan, JC; Miki, Y; Patel, U; Phillips, MD; Udupa, JK; van Buchem, MA; Wei, L | 1 |
Audano, L; Bergui, M; Bertolotto, A; Bradac, GB; Capobianco, M; Malucchi, S; Manzardo, E; Mutani, R | 1 |
Barker, GJ; Clark, CA; Droogan, AG; McDonald, WI; Miller, DH; Werring, DJ | 1 |
Bastianello, S; Comi, G; Filippi, M; Mastronardo, G; Prandini, F; Rovaris, M | 1 |
Fredrikson, S; Hindmarsh, T; Kivisäkk, P; Link, H; Matusevicius, D; Söderström, M; Stawiarz, L | 1 |
Bastianello, S; Ciccarelli, O; Comi, G; Faroni, J; Filippi, M; Gasperini, C; Giugni, E; Mainero, C; Pozzilli, C; Rovaris, M | 1 |
Losy, J; Niezgoda, A; Wender, M | 1 |
Bastianello, S; Fieschi, C; Galgani, S; Gasperini, C; Giugni, E; Haggiag, S; Horsfield, MA; Koudriavtseva, T; Millefiorini, E; Paolillo, A; Pozzilli, C | 1 |
Grossman, RI; Maldjian, JA; Roychowdhury, S | 1 |
Barker, GJ; Brassat, D; Clark, CA; Droogan, AG; MacManus, DG; Miller, DH; Symms, MR; Thompson, AJ; Werring, DJ | 1 |
Bastianello, S; Capra, R; Filippi, M; Gasperini, C; Paolillo, A; Rovaris, M; Yousry, TA | 1 |
Kira, J | 1 |
Capra, R; Filippi, M; Gasperini, C; Walther, E; Yousry, I; Yousry, TA | 1 |
Hagen, T; Schweigerer-Schröter, G; Wellnitz, J; Würstle, T | 1 |
Dragutinovic, G; Drulovic, J; Dujmovic, I; Ercegovac, M; Levic, Z; Mesaros, S; Peric, V; Sokic, DV; Stojsavljevic, N | 1 |
Kidd, D; Losseff, NA; Miller, DH; Thompson, AJ | 1 |
Bash, CN; Frank, JA; Leist, TP; McFarland, HF; Ostuni, JL; Richert, ND | 1 |
Barker, GJ; Miller, DH; Silver, NC; Symms, MR; Thompson, AJ; Tofts, PS | 1 |
Barkhof, F; Tan, IL; van der Meijs, AH | 1 |
Larsson, EM | 1 |
Amatruda, A; Cioffi, RP; Colosimo, M | 1 |
Barkhof, F; Frequin, ST; Hommes, OR; Lamers, K; Scheltens, P; Valk, J; van Geel, WJ | 1 |
Einig, M; Ernst, JP; Higer, HP; Mauz, M | 1 |
Koopmans, R; Li, DK; Paty, DW | 1 |
Airó, P; Bettinzioli, M; Capra, R; Cattaneo, R; Cotti Cometti, V; Gasparotti, R; Marcianó, N; Moretti, R; Vignolo, LA | 1 |
Rudick, RA | 1 |
Capra, R; Chiesa, A; Gasparotti, R; Marcianò, N; Vignolo, LA | 1 |
Algra, PR; Barkhof, F; Heijboer, RJ | 1 |
Christiansen, P; Frederiksen, JL; Henriksen, O; Larsson, HB | 1 |
Baker, K; Figiel, GS; Mattingly, G; Zorumski, CF | 1 |
Feinstein, A; Kendall, B; Kingsley, D; MacManus, D; McDonald, WI; Miller, D; Moore, S; Thompson, AJ; Youl, B | 1 |
Barkhof, F; Hommes, OR; Scheltens, P; Valk, J | 1 |
Burnham, JA; Dreisbach, J; Murray, RS; Wright, RR | 1 |
Kendall, BE; Kermode, AG; Kingsley, DP; MacManus, DG; McDonald, WI; Thompson, AJ; Wicks, D | 1 |
Hermes, M; Rüttinger, H; Rüttinger, P | 1 |
Kermode, AG; Tofts, PS | 2 |
Barnes, D; McDonald, WI; Munro, PM; Prineas, JW; Youl, BD | 1 |
Bronen, RA; Sze, G | 1 |
Kendall, BE; Kermode, AG; Kingsley, DP; MacManus, DG; McDonald, WI; Moseley, IF; Rudge, P; Thompson, AJ; Tofts, P | 1 |
Frederiksen, JL; Henriksen, O; Jensen, M; Larsson, HB; Paulson, OB; Stubgaard, M | 1 |
du Boulay, EP; Kendall, BE; Kermode, AG; Kingsley, DP; MacManus, DG; McDonald, WI; Moseley, IF; Rudge, P; Thompson, AJ; Tofts, PS | 1 |
Bastianello, S; Bernardi, S; Bozzao, L; Buttinelli, C; Fantozzi, LM; Fieschi, C; Pozzilli, C | 1 |
Hermes, M; Rüttinger, H | 1 |
Kendall, BE; Kermode, AG; Kingsley, DP; MacManus, DG; McDonald, WI; Moseley, IF; Thompson, AJ | 1 |
Barnes, D; Johnson, G; Kendall, BE; Macmanus, DG; McDonald, WI; Miller, DH; Moseley, IF; Rudge, P | 1 |
Braffman, BH; Brorson, JR; Goldberg, HI; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
Atlas, SW; Galetta, S; Gonzalez-Scarano, F; Grossman, RI; Silberberg, DH | 1 |
Appel, C; Gowin, W; Mariss, G; Weihe, W | 1 |
11 review(s) available for gadolinium dtpa and Multiple Sclerosis
Article | Year |
---|---|
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature.
Topics: Atrophy; Brain; Contrast Media; Disease Progression; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2002 |
Contrast use at low field: a review.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Joint Diseases; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds | 2003 |
Clinical-magnetic resonance imaging correlations in multiple sclerosis.
Topics: Atrophy; Brain; Contrast Media; Disability Evaluation; Disease Progression; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Sensitivity and Specificity; Spinal Cord | 2005 |
Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
Topics: Contrast Media; Disease Progression; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2006 |
[Magnetic resonance imaging of disseminated sclerosis].
Topics: Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1994 |
The use of brain magnetic resonance imaging in multiple sclerosis.
Topics: Brain; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Nervous System Diseases; Neuropsychological Tests; Organometallic Compounds; Pentetic Acid | 1994 |
Multiple sclerosis: what have we learned from magnetic resonance imaging studies?
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; Cognition; Cyclosporine; Gadolinium DTPA; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-alpha; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Prognosis; Psychomotor Performance; Severity of Illness Index; Treatment Outcome | 1998 |
Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns.
Topics: Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurosciences | 1998 |
[Neuroimaging and functional analyses for multiple sclerosis].
Topics: Contrast Media; Diagnosis, Differential; Evoked Potentials; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Magnetic resonance imaging in multiple sclerosis: an overview.
Topics: Brain; Diagnosis, Differential; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord | 1992 |
Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
Topics: Animals; Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meningitis; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Physical Phenomena; Physics; Pituitary Neoplasms; Postoperative Care; Spinal Cord Diseases; Spinal Cord Neoplasms | 1990 |
19 trial(s) available for gadolinium dtpa and Multiple Sclerosis
Article | Year |
---|---|
Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis.
Topics: Brain; Contrast Media; Female; Gadolinium DTPA; Gray Matter; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; White Matter | 2014 |
Serum uric acid and multiple sclerosis.
Topics: Adolescent; Adult; Chronic Disease; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Predictive Value of Tests; Reference Values; Severity of Illness Index; Sex Factors; Uric Acid | 2002 |
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial.
Topics: Adjuvants, Immunologic; Contrast Media; Drug Administration Schedule; Gadolinium DTPA; Glatiramer Acetate; Humans; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Multiple Sclerosis; Peptides; Safety | 2005 |
MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).
Topics: Adult; Brain; Canada; Contrast Media; Disease Progression; Double-Blind Method; Europe; Female; Gadolinium DTPA; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Placebos; Reproducibility of Results; Treatment Outcome | 2005 |
[Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase].
Topics: Acute Disease; Adolescent; Adult; Aged; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.
Topics: Adolescent; Adult; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neurologic Examination; Organometallic Compounds; Pentetic Acid | 1994 |
Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Time Factors | 1996 |
Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study.
Topics: Adult; Autoimmune Diseases; Azathioprine; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pilot Projects; Plasma Exchange; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 1996 |
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.
Topics: Adolescent; Adult; Brain; Female; Gadolinium DTPA; Humans; Injections, Subcutaneous; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Research Design; Treatment Outcome | 1996 |
High-dose contrast-enhanced MRI in multiple sclerosis.
Topics: Adult; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1996 |
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Topics: Adult; Biomarkers; Brain; Cell Adhesion Molecules, Neuronal; Cerebrospinal Fluid; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 1997 |
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.
Topics: Adult; Antiviral Agents; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Monitoring, Physiologic; Multiple Sclerosis; Recurrence | 1996 |
Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway.
Topics: Contrast Media; Double-Blind Method; Gadolinium DTPA; Humans; Interferon alpha-2; Interferon-alpha; Magnetic Resonance Imaging; Multiple Sclerosis; Norway; Recombinant Proteins; Recurrence; Remission Induction | 1996 |
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis.
Topics: Adult; Anti-Inflammatory Agents; Brain; Gadolinium DTPA; Humans; Interferon beta-1a; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Recombinant Proteins; Recurrence; Time Factors | 1998 |
Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis.
Topics: Adult; Antiviral Agents; Blood-Brain Barrier; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Recurrence; Respiratory Tract Infections; Severity of Illness Index | 1998 |
Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.
Topics: Adjuvants, Immunologic; Adult; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Intercellular Adhesion Molecule-1; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recombinant Proteins; Solubility | 1998 |
A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
Topics: Adult; Aged; Clinical Trials, Phase II as Topic; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Research Design; Sensitivity and Specificity; Time Factors | 1998 |
Correlation between MRI and short-term clinical activity in multiple sclerosis: comparison between standard- and triple-dose Gd-enhanced MRI.
Topics: Adult; Aged; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Image Enhancement; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 1999 |
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images.
Topics: Adult; Brain; Disabled Persons; Female; Gadolinium DTPA; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Predictive Value of Tests; Prognosis; Treatment Outcome | 1999 |
137 other study(ies) available for gadolinium dtpa and Multiple Sclerosis
Article | Year |
---|---|
Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.
Topics: Case-Control Studies; Cerebellar Nuclei; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2022 |
Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.
Topics: Adult; Contrast Media; Cross-Sectional Studies; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Processing Speed; Retrospective Studies | 2023 |
MRI detection of brain gadolinium retention in multiple sclerosis: Magnetization transfer vs. T1-weighted imaging.
Topics: Brain; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Retrospective Studies | 2023 |
Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.
Topics: Adult; Cerebellar Nuclei; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies; Scalp | 2023 |
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis.
Topics: Cerebellar Nuclei; Cognition; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2023 |
T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis.
Topics: Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2021 |
Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
Topics: Cerebellar Nuclei; Contrast Media; Female; Gadolinium DTPA; Gray Matter; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Retrospective Studies; Software | 2020 |
Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Topics: Cerebellar Nuclei; Contrast Media; Gadolinium DTPA; Gray Matter; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Retrospective Studies | 2022 |
Differentiating enhancing multiple sclerosis lesions, glioblastoma, and lymphoma with dynamic texture parameters analysis (DTPA): A feasibility study.
Topics: Brain Neoplasms; Contrast Media; Diagnosis, Differential; Feasibility Studies; Gadolinium; Gadolinium DTPA; Glioblastoma; Humans; Image Enhancement; Lymphoma; Magnetic Resonance Imaging; Multiple Sclerosis | 2017 |
Disease stage-dependent relationship between diffusion tensor imaging and electrophysiology of the visual system in a murine model of multiple sclerosis.
Topics: Animals; Contrast Media; Diffusion Tensor Imaging; Disease Models, Animal; Disease Progression; Electrophysiology; Evoked Potentials, Visual; Female; Gadolinium DTPA; Image Processing, Computer-Assisted; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Optic Nerve; White Matter | 2017 |
Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
Topics: Adult; Brain; Contrast Media; Cross-Sectional Studies; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuroimaging | 2019 |
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
Topics: Adult; Brain; Contrast Media; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2019 |
Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Topics: Brain; Cervical Cord; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2019 |
Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years.
Topics: Adult; Area Under Curve; Contrast Media; Disability Evaluation; Disease Progression; Electric Stimulation; Electroencephalography; Evoked Potentials, Motor; Evoked Potentials, Visual; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Photic Stimulation; Predictive Value of Tests; Prospective Studies; Reaction Time; ROC Curve; Time Factors | 2014 |
Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
Topics: Brain Neoplasms; Cerebellar Nuclei; Chelating Agents; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2014 |
Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.
Topics: Acute Disease; Animals; Chronic Disease; Contrast Media; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Gadolinium DTPA; Mice; Multiple Sclerosis; Peroxidase; Radionuclide Imaging | 2015 |
Science to practice: myeloperoxidase immunoradiology improves detection of acute and chronic experimental multiple sclerosis.
Topics: Animals; Contrast Media; Female; Gadolinium DTPA; Multiple Sclerosis; Peroxidase; Radionuclide Imaging | 2015 |
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Topics: Adult; Aged; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Young Adult | 2016 |
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Topics: Brain; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuroimaging; Spinal Cord | 2016 |
Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
Topics: Animals; Brain Stem; Cerebellum; Contrast Media; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Multiple Sclerosis; Optic Nerve; Organometallic Compounds; Rats; Rats, Inbred Strains; Spinal Cord | 2008 |
Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
Topics: Adult; Algorithms; Atrophy; Brain; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Sensitivity and Specificity; Software | 2008 |
Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Prospective Studies; Young Adult | 2009 |
Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
Topics: Blood-Brain Barrier; Brain; Brain Diseases; Capillary Permeability; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis | 2009 |
Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Topics: Adolescent; Adult; Brain Chemistry; Brain Diseases; Contrast Media; Demyelinating Diseases; Diagnosis, Differential; Disability Evaluation; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 2011 |
Modifications to the McDonald MRI dissemination in space criteria for use in Asians with classic multiple sclerosis: the Taiwanese experience.
Topics: Adolescent; Adult; Asian People; Brain; Cohort Studies; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Spinal Cord; Taiwan; Young Adult | 2010 |
T2 hypointense rims and ring-enhancing lesions in MS.
Topics: Adolescent; Adult; Aged; Brain; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2010 |
Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
Topics: Animals; Astrocytes; Blotting, Western; Brain; Coculture Techniques; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Gadolinium DTPA; Image Processing, Computer-Assisted; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Nitrites; Spleen | 2010 |
Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
Topics: Adipose Tissue; Adult; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Prospective Studies | 2011 |
Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Principal Component Analysis | 2011 |
VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.
Topics: Animals; Brain; Contrast Media; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Endothelium; Female; Ferric Compounds; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Multiple Sclerosis; Translational Research, Biomedical; Vascular Cell Adhesion Molecule-1 | 2011 |
Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Topics: Adolescent; Adult; Aspartic Acid; Brain; Brain Mapping; Child; Choline; Contrast Media; Demyelinating Diseases; Diffusion Magnetic Resonance Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Image Enhancement; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Young Adult | 2011 |
Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins.
Topics: Analysis of Variance; Blood Flow Velocity; Constriction, Pathologic; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Jugular Veins; Magnetic Resonance Angiography; Male; Multiple Sclerosis; Organometallic Compounds | 2012 |
Tissue similarity maps (TSMs): a new means of mapping vascular behavior and calculating relative blood volume in perfusion weighted imaging.
Topics: Adult; Algorithms; Blood Flow Velocity; Blood Volume Determination; Cerebral Arteries; Cerebrovascular Circulation; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Middle Aged; Multiple Sclerosis; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.
Topics: Adult; Brain; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Prognosis; Time Factors | 2003 |
[The characteristics of enhanced gadolinium DTPA brain magnetic resonance images in 298 multiple sclerosis patients].
Topics: Adolescent; Adult; Aged; Brain; Child; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2003 |
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
Topics: Adult; Aspartic Acid; Brain; Chromatography, High Pressure Liquid; Disability Evaluation; Gadolinium DTPA; Glutamic Acid; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Spinal Cord | 2003 |
Safety of the long-time monthly triple dose of a Gd-based contrast agent.
Topics: Adult; Aged; Cohort Studies; Contrast Media; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gadolinium DTPA; Humans; Long-Term Care; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multiple Sclerosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index | 2003 |
Redefinition of multiple sclerosis plaque size using diffusion tensor MRI.
Topics: Adult; Aged; Anisotropy; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies | 2004 |
Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Contrast Media; Gadolinium DTPA; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Multiple Sclerosis | 2004 |
Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
Topics: Adult; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium DTPA; Humans; Image Enhancement; Immunoglobulin G; Immunoprecipitation; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Nephelometry and Turbidimetry; Solubility; Statistics as Topic; Statistics, Nonparametric; Time Factors | 2005 |
Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
Topics: Adolescent; Adult; Brain; Computer Simulation; Contrast Media; Female; Gadolinium DTPA; History, 18th Century; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Statistics, Nonparametric | 2005 |
Gadolinium dose optimisation in patients with multiple sclerosis: intra- and inter-individual comparisons.
Topics: Adult; Child; Contrast Media; Female; Gadolinium DTPA; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Statistics, Nonparametric | 2006 |
Steady state of gradient echo sequences with radiofrequency phase cycling: analytical solution, contrast enhancement with partial spoiling.
Topics: Adult; Aged; Brain Mapping; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Multiple Sclerosis | 2006 |
ADC measurements in various patterns of multiple sclerosis lesions.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Confidence Intervals; Diffusion Magnetic Resonance Imaging; Disability Evaluation; Disease Progression; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sex Factors; Statistics, Nonparametric | 2006 |
Comparing MR image intensity standardization against tissue characterizability of magnetization transfer ratio imaging.
Topics: Brain; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetics; Models, Statistical; Multiple Sclerosis; Reference Standards | 2006 |
Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.
Topics: Animals; Brain; Callithrix; Disease Models, Animal; Gadolinium DTPA; Magnetic Resonance Imaging; Multiple Sclerosis | 2007 |
Microvessel density estimation in the human brain by means of dynamic contrast-enhanced echo-planar imaging.
Topics: Adult; Algorithms; Brain; Contrast Media; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Microcirculation; Multiple Sclerosis; Reproducibility of Results; Sensitivity and Specificity; Spin Labels | 2006 |
Mouse model mimics multiple sclerosis in the clinico-radiological paradox.
Topics: Animals; Blood-Brain Barrier; Brain; Cerebellum; Contrast Media; Cranial Nerves; Disease Models, Animal; Endocytosis; Female; Fluorocarbons; Gadolinium DTPA; Image Processing, Computer-Assisted; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Microglia; Multiple Sclerosis; Organometallic Compounds; Phagocytosis; Radiography; T-Lymphocytes | 2007 |
Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
Topics: Adult; Analysis of Variance; Atrophy; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Retrospective Studies; Statistics, Nonparametric | 2007 |
Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
Topics: Adolescent; Adult; Chi-Square Distribution; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity | 2008 |
The evolution of multiple sclerosis lesions on serial MR.
Topics: Adult; Brain; Contrast Media; Drug Combinations; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1995 |
In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy.
Topics: Adult; Axons; Blood-Brain Barrier; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis; Myelin Sheath; Neurologic Examination; Organometallic Compounds; Pentetic Acid | 1995 |
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Sensitivity and Specificity | 1995 |
Optic neuritis with silent cerebral lesions: availability of FLAIR sequences.
Topics: Brain; Child; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Organometallic Compounds; Pentetic Acid | 1995 |
Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
Topics: Acute Disease; Adolescent; Adult; Aged; Brain; Contrast Media; Diagnosis, Differential; Drug Combinations; Encephalomyelitis; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Myelitis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Spinal Cord Diseases | 1995 |
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
Topics: Antigens, CD; Antigens, Neoplasm; Brain; CD52 Antigen; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Glycoproteins; Humans; Lymphocyte Depletion; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1994 |
Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Time Factors | 1994 |
Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.
Topics: Adult; Blood-Brain Barrier; Brain; Chronic Disease; Clinical Trials as Topic; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Recurrence; Severity of Illness Index; Treatment Outcome | 1994 |
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.
Topics: Adult; Aspartic Acid; Creatine; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1994 |
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
Topics: Adult; Brain; Cerebral Cortex; Chronic Disease; Contrast Media; Female; Gadolinium DTPA; HLA Antigens; Humans; Immunohistochemistry; Macrophages; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pons; Spinal Cord | 1993 |
Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area.
Topics: Adolescent; Cerebral Cortex; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Headache; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Periaqueductal Gray | 1993 |
Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Infant, Newborn; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy Trimester, Second; Puerperal Disorders | 1994 |
MRI of the brain stem using fluid attenuated inversion recivery pulse sequences.
Topics: Adult; Brain Diseases; Brain Neoplasms; Brain Stem; Cerebral Infarction; Cerebrospinal Fluid Shunts; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Hydrocephalus; Lung Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Sarcoidosis | 1993 |
Database for serial magnetic resonance imaging in multiple sclerosis.
Topics: Brain; Contrast Media; Data Collection; Databases, Bibliographic; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Medical Records Systems, Computerized; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Software | 1993 |
Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS.
Topics: Adult; Brain; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Nerve Fibers, Myelinated; Neuropsychological Tests; Organometallic Compounds; Pentetic Acid; Spinal Cord | 1993 |
Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig.
Topics: Animals; Blood-Brain Barrier; Brain; Contrast Media; Encephalomyelitis, Autoimmune, Experimental; Gadolinium; Gadolinium DTPA; Guinea Pigs; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1993 |
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
Topics: Adult; Brain; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prednisone; Recurrence; Remission, Spontaneous; Spine; Time Factors; Visual Acuity | 1993 |
Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
Topics: Adult; Analysis of Variance; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1995 |
Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis.
Topics: Adult; Blood-Retinal Barrier; Brain; Capillary Permeability; Contrast Media; Female; Fluorescein Angiography; Fundus Oculi; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Phlebitis; Prospective Studies; Recurrence; Retinal Diseases; Retinal Vein | 1996 |
MRI dynamics of brain and spinal cord in progressive multiple sclerosis.
Topics: Atrophy; Brain; Contrast Media; Disabled Persons; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prognosis; Recurrence; Remission, Spontaneous; Spinal Cord | 1996 |
A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Contrast Media; Disabled Persons; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Sensitivity and Specificity; Severity of Illness Index; Time Factors | 1996 |
Balo's concentric sclerosis. Report of two patients with magnetic resonance imaging follow-up.
Topics: Adult; Brain Diseases; Contrast Media; Diffuse Cerebral Sclerosis of Schilder; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Remission, Spontaneous | 1996 |
Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Dominance, Cerebral; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Reference Values | 1996 |
Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
Topics: Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Time Factors | 1996 |
Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.
Topics: Adjuvants, Immunologic; Adult; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Nerve Fibers, Myelinated; Organometallic Compounds; Pentetic Acid | 1996 |
Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
Topics: Adolescent; Adult; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium DTPA; Humans; Intercellular Adhesion Molecule-1; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1996 |
Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis.
Topics: Adult; Antigens, CD; Brain; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules; Cell Separation; Female; Flow Cytometry; Gadolinium DTPA; Humans; Lymphocyte Activation; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1996 |
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
Topics: Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Prospective Studies; Receptors, Tumor Necrosis Factor; Recurrence; Tumor Necrosis Factor-alpha | 1996 |
Blood-CSF barrier integrity in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Capillary Permeability; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Serum Albumin; Spinal Cord; Spinal Puncture | 1996 |
Clinical safety of serial monthly administrations of gadopentetate dimeglumine in patients with multiple sclerosis: implications for natural history and early-phase treatment trials.
Topics: Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Contrast Media; Drug Administration Schedule; Female; Gadolinium DTPA; Hemoglobins; Humans; Longitudinal Studies; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Safety | 1997 |
Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability.
Topics: Activities of Daily Living; Adult; Brain; Computer Systems; Contrast Media; Disability Evaluation; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurologic Examination; Prospective Studies; Software | 1997 |
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure.
Topics: Adjuvants, Immunologic; Adult; Blood-Brain Barrier; Brain; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Injections, Subcutaneous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recombinant Proteins; Self Administration; Treatment Outcome | 1997 |
Diffusion-weighted imaging of the human optic nerve: a new approach to evaluate optic neuritis in multiple sclerosis.
Topics: Adolescent; Adult; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Optic Nerve; Optic Neuritis | 1997 |
Multiple sclerosis lesion quantification using fuzzy-connectedness principles.
Topics: Algorithms; Brain; Clinical Protocols; Computer Peripherals; Confidence Intervals; Contrast Media; Database Management Systems; Disease Progression; Evaluation Studies as Topic; False Negative Reactions; Fuzzy Logic; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Observer Variation; Reproducibility of Results | 1997 |
Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination.
Topics: Adolescent; Adult; Brain Stem; Female; Gadolinium DTPA; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Optic Nerve; Prognosis; Prospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Spinal Cord | 1998 |
A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
Topics: Adult; Aged; Brain Diseases; Contrast Media; Disability Evaluation; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity | 1998 |
Automatic segmentation of gadolinium-enhanced multiple sclerosis lesions.
Topics: Algorithms; Anisotropy; Artifacts; Blood-Brain Barrier; Brain; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Multiple Sclerosis; Sensitivity and Specificity | 1998 |
Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis.
Topics: Adult; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Male; Multiple Sclerosis; Neck; Sensitivity and Specificity; Spinal Cord; Thorax | 1998 |
MRI evolution of new MS lesions enhancing after different doses of gadolinium.
Topics: Blood-Brain Barrier; Brain; Contrast Media; Dose-Response Relationship, Drug; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Multiple Sclerosis | 1998 |
Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Disability Evaluation; Estradiol; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Menstrual Cycle; Multiple Sclerosis; Progesterone; Sensitivity and Specificity | 1999 |
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results.
Topics: Adolescent; Adult; Clinical Trials as Topic; Computer Simulation; Cross-Over Studies; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Models, Statistical; Multicenter Studies as Topic; Multiple Sclerosis; Recurrence; Research Design; Sample Size; Statistics, Nonparametric | 1999 |
Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging.
Topics: Adult; Anatomy, Cross-Sectional; Brain; Brain Diseases; Cerebrospinal Fluid; Chronic Disease; Contrast Media; Disabled Persons; Disease Progression; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Middle Aged; Movement Disorders; Multiple Sclerosis; Prospective Studies; Recurrence | 1999 |
Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.
Topics: Adult; Brain; Female; Gadolinium DTPA; Humans; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence; RNA, Messenger; Statistics, Nonparametric; Transcription, Genetic; Transforming Growth Factor beta | 1999 |
Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging.
Topics: Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Statistics, Nonparametric | 1999 |
Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans.
Topics: Adult; Brain; Cohort Studies; Contrast Media; Disease Progression; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Time Factors | 1999 |
High numbers of perforin mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions.
Topics: Adult; Aged; Brain; Cerebrospinal Fluid Proteins; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; In Situ Hybridization; Interleukin-10; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Middle Aged; Multiple Sclerosis; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Fatigue and magnetic resonance imaging activity in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Brain; Contrast Media; Fatigue; Female; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Recurrence; Severity of Illness Index | 1999 |
Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions.
Topics: Adult; Cell Movement; Contrast Media; Enzyme-Linked Immunosorbent Assay; Female; Gadolinium DTPA; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Endothelial Cell Adhesion Molecule-1; Solubility | 1999 |
Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions.
Topics: Adult; Brain; Contrast Media; Diffusion; Disease Progression; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Myelin Sheath; Sensitivity and Specificity | 2000 |
The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study.
Topics: Adult; Brain; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Reference Values | 2000 |
A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
Topics: Adult; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Sensitivity and Specificity | 2000 |
Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose.
Topics: Adult; Contrast Media; Female; Gadolinium DTPA; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity; Spinal Cord Diseases | 2000 |
[Diffusion-weighted magnetic resonance tomography in diagnosis of encephalitis disseminata].
Topics: Adolescent; Adult; Brain; Contrast Media; Diagnosis, Differential; Diffusion; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Sensitivity and Specificity; Spinal Cord | 2000 |
Seizures in multiple sclerosis.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anticonvulsants; Atrophy; Brain; Carbamazepine; Child; Chronic Disease; Comorbidity; Electroencephalography; Epilepsy; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Recurrence; Seizures; Treatment Outcome | 2001 |
The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis--preliminary results.
Topics: Adult; Autoimmune Diseases; Blood-Brain Barrier; Brain; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Pilot Projects; Prognosis | 2001 |
Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Blood-Brain Barrier; Brain; Contrast Media; Cross-Over Studies; Drug Evaluation; Drug Therapy, Combination; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Intravenous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Treatment Outcome | 2001 |
Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study.
Topics: Adult; Blood-Brain Barrier; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis | 2001 |
Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis.
Topics: Adolescent; Adult; Clinical Trials, Phase III as Topic; Demyelinating Diseases; Female; Gadolinium DTPA; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Trigeminal Nerve; Trigeminal Nerve Diseases | 2002 |
Magnetic resonance imaging of the cervical and thoracic spine and the spinal cord. A study using a 0.3 T vertical magnetic field.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cervical Vertebrae; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Models, Structural; Multiple Sclerosis; Myelography; Organometallic Compounds; Pentetic Acid; Spinal Cord Compression; Spinal Cord Diseases; Spinal Diseases; Thoracic Vertebrae; Tomography, X-Ray Computed | 1992 |
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.
Topics: Adult; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Organometallic Compounds; Pentetic Acid | 1992 |
[Intracranial tumor-like lesions in children and young adults with multiple sclerosis].
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Time Factors | 1992 |
Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
Topics: Adult; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Sensitivity and Specificity; Time Factors | 1992 |
MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines.
Topics: Blood-Brain Barrier; Brain; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1992 |
Immunological and gadolinium-DTPA MRI evaluation of relapsing remitting multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; CD4-CD8 Ratio; Contrast Media; Female; Gadolinium DTPA; Humans; Leukocyte Count; Lymphocyte Activation; Lymphocyte Subsets; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Receptors, Interleukin-2 | 1992 |
The value of brain magnetic resonance imaging in multiple sclerosis.
Topics: Brain; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1992 |
Gadolinium-pentetic acid magnetic resonance imaging in patients with relapsing remitting multiple sclerosis.
Topics: Adult; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Radionuclide Imaging; Recurrence | 1992 |
Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
Topics: Adult; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Pregnancy | 1992 |
Gd-DTPA-enhanced lesions in the brain of patients with acute optic neuritis.
Topics: Adult; Blood-Brain Barrier; Brain; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Organometallic Compounds; Pentetic Acid | 1992 |
Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.
Topics: Adult; Brain; Contrast Media; Depressive Disorder; Electroconvulsive Therapy; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neurocognitive Disorders; Neurologic Examination; Neuropsychological Tests; Organometallic Compounds; Pentetic Acid | 1992 |
Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
Topics: Adult; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Time Factors | 1992 |
Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
The effect of high-dose steroids on MRI gadolinium enhancement in acute demyelinating lesions.
Topics: Adult; Blood-Brain Barrier; Brain; Encephalomyelitis; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
Major differences in the dynamics of primary and secondary progressive multiple sclerosis.
Topics: Adult; Brain; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
[Cerebrospinal fluid IgG and the blood-brain barrier in multiple sclerosis. A new viewpoint].
Topics: Adult; Blood-Brain Barrier; Contrast Media; Female; Gadolinium DTPA; Humans; Immunoglobulin G; Immunoglobulins; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Oligoclonal Bands; Organometallic Compounds; Pentetic Acid; Serum Albumin | 1991 |
Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.
Topics: Adult; Blood-Brain Barrier; Brain Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Kidney; Magnetic Resonance Imaging; Models, Biological; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Permeability; Time Factors | 1991 |
The longstanding MS lesion. A quantitative MRI and electron microscopic study.
Topics: Adult; Brain; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1991 |
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.
Topics: Adult; Blood-Brain Barrier; Brain; Contrast Media; Disability Evaluation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors.
Topics: Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Models, Biological; Models, Chemical; Models, Structural; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
Topics: Adolescent; Adult; Blood-Brain Barrier; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid | 1990 |
[Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
Topics: Adult; Brain; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Organometallic Compounds; Pentetic Acid | 1990 |
Blood brain barrier permeability in multiple sclerosis using labelled DTPA with PET, CT and MRI.
Topics: Blood-Brain Barrier; Capillary Permeability; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Infant, Newborn; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Pathogenesis of progressive multiple sclerosis.
Topics: Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Recurrence; Severity of Illness Index | 1989 |
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Topics: Adult; Blood-Brain Barrier; Brain; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Spinal Cord; Time Factors | 1988 |
Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Blood-Brain Barrier; Brain; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Time Factors | 1988 |
Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Brain; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Meglumine; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Sorbitol; Tomography, X-Ray Computed | 1987 |
[Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Pentetic Acid | 1986 |